TP53 and breast cancer: Although germline TP53 mutations are uncommon, occurring in approximately 1% of all BC cases, carriers face a significantly elevated lifetime risk of developing the disease, estimated at 80–90%, which is higher than that associated with most other susceptibility genes [97].